Key facts
- Karyopharm Therapeutics Inc. filed a Form 13G on June 5th.
- The filing is a beneficial ownership report.
- Form 13G is used for passive stakes in public companies.
Karyopharm Therapeutics Inc. has filed a Form 13G with the Securities and Exchange Commission (SEC) on June 5th. This filing is a beneficial ownership report, typically indicating a passive stake held by institutional investors in a publicly traded company.